ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-TIGIT Antibody Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-1W9149
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti TIGIT Antibody Market Research Report 2022
BUY CHAPTERS

Global Anti-TIGIT Antibody Market Research Report 2025

Code: QYRE-Auto-1W9149
Report
July 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Merck
Astrazeneca plc
Arcus
Astellas
BeiGene Ltd
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
Gilead Sciences

Anti-TIGIT Antibody Market Size

The global market for Anti-TIGIT Antibody was valued at US$ 412 million in the year 2024 and is projected to reach a revised size of US$ 991 million by 2031, growing at a CAGR of 13.5% during the forecast period.

Anti-TIGIT Antibody Market

Anti-TIGIT Antibody Market

A human monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity.
TIGIT (T cell immunoreceptor with Ig and ITIM domains) is a protein receptor found on various immune cells, including T cells and natural killer (NK) cells. It plays a role in regulating immune responses, and targeting TIGIT has emerged as a potential therapeutic strategy for cancer and autoimmune diseases.
Clinical trials were underway to evaluate the safety and efficacy of anti-TIGIT antibodies either as monotherapy or in combination with other immunotherapies, such as checkpoint inhibitors (e.g., anti-PD-1/PD-L1 antibodies). Promising results were reported from early-stage trials, showing potential benefits in various solid tumors, including lung cancer, melanoma, and gastrointestinal cancers.
The market for anti-TIGIT antibodies was expected to grow as more clinical data became available.
This report aims to provide a comprehensive presentation of the global market for Anti-TIGIT Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-TIGIT Antibody.
The Anti-TIGIT Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-TIGIT Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-TIGIT Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-TIGIT Antibody Market Report

Report Metric Details
Report Name Anti-TIGIT Antibody Market
Accounted market size in year US$ 412 million
Forecasted market size in 2031 US$ 991 million
CAGR 13.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Merck, AstraZeneca, Arcus, Astellas, BeiGene, BMS, Junshi Biosciences, Innovent Biologics, Mereo BioPharma, Seattle Genetics, Hengrui Medicine, Compugen, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anti-TIGIT Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-TIGIT Antibody Market growing?

Ans: The Anti-TIGIT Antibody Market witnessing a CAGR of 13.5% during the forecast period 2025-2031.

What is the Anti-TIGIT Antibody Market size in 2031?

Ans: The Anti-TIGIT Antibody Market size in 2031 will be US$ 991 million.

Who are the main players in the Anti-TIGIT Antibody Market report?

Ans: The main players in the Anti-TIGIT Antibody Market are Roche, Merck, AstraZeneca, Arcus, Astellas, BeiGene, BMS, Junshi Biosciences, Innovent Biologics, Mereo BioPharma, Seattle Genetics, Hengrui Medicine, Compugen, Gilead Sciences

What are the Application segmentation covered in the Anti-TIGIT Antibody Market report?

Ans: The Applications covered in the Anti-TIGIT Antibody Market report are Cell Carcinoma, Solid Tumor

What are the Type segmentation covered in the Anti-TIGIT Antibody Market report?

Ans: The Types covered in the Anti-TIGIT Antibody Market report are Monotherapy, Combination Therapy

Recommended Reports

Antibody Market

Immune Therapy

Biosimilars & Conjugates

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-TIGIT Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Anti-TIGIT Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cell Carcinoma
1.3.3 Solid Tumor
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-TIGIT Antibody Market Perspective (2020-2031)
2.2 Global Anti-TIGIT Antibody Growth Trends by Region
2.2.1 Global Anti-TIGIT Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-TIGIT Antibody Historic Market Size by Region (2020-2025)
2.2.3 Anti-TIGIT Antibody Forecasted Market Size by Region (2026-2031)
2.3 Anti-TIGIT Antibody Market Dynamics
2.3.1 Anti-TIGIT Antibody Industry Trends
2.3.2 Anti-TIGIT Antibody Market Drivers
2.3.3 Anti-TIGIT Antibody Market Challenges
2.3.4 Anti-TIGIT Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-TIGIT Antibody Players by Revenue
3.1.1 Global Top Anti-TIGIT Antibody Players by Revenue (2020-2025)
3.1.2 Global Anti-TIGIT Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-TIGIT Antibody Revenue
3.4 Global Anti-TIGIT Antibody Market Concentration Ratio
3.4.1 Global Anti-TIGIT Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-TIGIT Antibody Revenue in 2024
3.5 Global Key Players of Anti-TIGIT Antibody Head office and Area Served
3.6 Global Key Players of Anti-TIGIT Antibody, Product and Application
3.7 Global Key Players of Anti-TIGIT Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-TIGIT Antibody Breakdown Data by Type
4.1 Global Anti-TIGIT Antibody Historic Market Size by Type (2020-2025)
4.2 Global Anti-TIGIT Antibody Forecasted Market Size by Type (2026-2031)
5 Anti-TIGIT Antibody Breakdown Data by Application
5.1 Global Anti-TIGIT Antibody Historic Market Size by Application (2020-2025)
5.2 Global Anti-TIGIT Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-TIGIT Antibody Market Size (2020-2031)
6.2 North America Anti-TIGIT Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-TIGIT Antibody Market Size by Country (2020-2025)
6.4 North America Anti-TIGIT Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-TIGIT Antibody Market Size (2020-2031)
7.2 Europe Anti-TIGIT Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-TIGIT Antibody Market Size by Country (2020-2025)
7.4 Europe Anti-TIGIT Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-TIGIT Antibody Market Size (2020-2031)
8.2 Asia-Pacific Anti-TIGIT Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-TIGIT Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-TIGIT Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-TIGIT Antibody Market Size (2020-2031)
9.2 Latin America Anti-TIGIT Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-TIGIT Antibody Market Size by Country (2020-2025)
9.4 Latin America Anti-TIGIT Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-TIGIT Antibody Market Size (2020-2031)
10.2 Middle East & Africa Anti-TIGIT Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Anti-TIGIT Antibody Introduction
11.1.4 Roche Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Anti-TIGIT Antibody Introduction
11.2.4 Merck Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.2.5 Merck Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Anti-TIGIT Antibody Introduction
11.3.4 AstraZeneca Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Arcus
11.4.1 Arcus Company Details
11.4.2 Arcus Business Overview
11.4.3 Arcus Anti-TIGIT Antibody Introduction
11.4.4 Arcus Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.4.5 Arcus Recent Development
11.5 Astellas
11.5.1 Astellas Company Details
11.5.2 Astellas Business Overview
11.5.3 Astellas Anti-TIGIT Antibody Introduction
11.5.4 Astellas Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.5.5 Astellas Recent Development
11.6 BeiGene
11.6.1 BeiGene Company Details
11.6.2 BeiGene Business Overview
11.6.3 BeiGene Anti-TIGIT Antibody Introduction
11.6.4 BeiGene Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.6.5 BeiGene Recent Development
11.7 BMS
11.7.1 BMS Company Details
11.7.2 BMS Business Overview
11.7.3 BMS Anti-TIGIT Antibody Introduction
11.7.4 BMS Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.7.5 BMS Recent Development
11.8 Junshi Biosciences
11.8.1 Junshi Biosciences Company Details
11.8.2 Junshi Biosciences Business Overview
11.8.3 Junshi Biosciences Anti-TIGIT Antibody Introduction
11.8.4 Junshi Biosciences Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.8.5 Junshi Biosciences Recent Development
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Details
11.9.2 Innovent Biologics Business Overview
11.9.3 Innovent Biologics Anti-TIGIT Antibody Introduction
11.9.4 Innovent Biologics Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.9.5 Innovent Biologics Recent Development
11.10 Mereo BioPharma
11.10.1 Mereo BioPharma Company Details
11.10.2 Mereo BioPharma Business Overview
11.10.3 Mereo BioPharma Anti-TIGIT Antibody Introduction
11.10.4 Mereo BioPharma Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.10.5 Mereo BioPharma Recent Development
11.11 Seattle Genetics
11.11.1 Seattle Genetics Company Details
11.11.2 Seattle Genetics Business Overview
11.11.3 Seattle Genetics Anti-TIGIT Antibody Introduction
11.11.4 Seattle Genetics Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.11.5 Seattle Genetics Recent Development
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Details
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine Anti-TIGIT Antibody Introduction
11.12.4 Hengrui Medicine Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.12.5 Hengrui Medicine Recent Development
11.13 Compugen
11.13.1 Compugen Company Details
11.13.2 Compugen Business Overview
11.13.3 Compugen Anti-TIGIT Antibody Introduction
11.13.4 Compugen Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.13.5 Compugen Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Anti-TIGIT Antibody Introduction
11.14.4 Gilead Sciences Revenue in Anti-TIGIT Antibody Business (2020-2025)
11.14.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche
Merck
Astrazeneca plc
Arcus
Astellas
BeiGene Ltd
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
Gilead Sciences
List of Tables
 Table 1. Global Anti-TIGIT Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monotherapy
 Table 3. Key Players of Combination Therapy
 Table 4. Global Anti-TIGIT Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Anti-TIGIT Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Anti-TIGIT Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Anti-TIGIT Antibody Market Share by Region (2020-2025)
 Table 8. Global Anti-TIGIT Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Anti-TIGIT Antibody Market Share by Region (2026-2031)
 Table 10. Anti-TIGIT Antibody Market Trends
 Table 11. Anti-TIGIT Antibody Market Drivers
 Table 12. Anti-TIGIT Antibody Market Challenges
 Table 13. Anti-TIGIT Antibody Market Restraints
 Table 14. Global Anti-TIGIT Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Anti-TIGIT Antibody Market Share by Players (2020-2025)
 Table 16. Global Top Anti-TIGIT Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2024)
 Table 17. Ranking of Global Top Anti-TIGIT Antibody Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Anti-TIGIT Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Anti-TIGIT Antibody, Headquarters and Area Served
 Table 20. Global Key Players of Anti-TIGIT Antibody, Product and Application
 Table 21. Global Key Players of Anti-TIGIT Antibody, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Anti-TIGIT Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Anti-TIGIT Antibody Revenue Market Share by Type (2020-2025)
 Table 25. Global Anti-TIGIT Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Anti-TIGIT Antibody Revenue Market Share by Type (2026-2031)
 Table 27. Global Anti-TIGIT Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Anti-TIGIT Antibody Revenue Market Share by Application (2020-2025)
 Table 29. Global Anti-TIGIT Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Anti-TIGIT Antibody Revenue Market Share by Application (2026-2031)
 Table 31. North America Anti-TIGIT Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Anti-TIGIT Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Anti-TIGIT Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Anti-TIGIT Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Anti-TIGIT Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Anti-TIGIT Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Anti-TIGIT Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Anti-TIGIT Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Anti-TIGIT Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-TIGIT Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Anti-TIGIT Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Anti-TIGIT Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Anti-TIGIT Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Roche Company Details
 Table 47. Roche Business Overview
 Table 48. Roche Anti-TIGIT Antibody Product
 Table 49. Roche Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 50. Roche Recent Development
 Table 51. Merck Company Details
 Table 52. Merck Business Overview
 Table 53. Merck Anti-TIGIT Antibody Product
 Table 54. Merck Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 55. Merck Recent Development
 Table 56. AstraZeneca Company Details
 Table 57. AstraZeneca Business Overview
 Table 58. AstraZeneca Anti-TIGIT Antibody Product
 Table 59. AstraZeneca Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 60. AstraZeneca Recent Development
 Table 61. Arcus Company Details
 Table 62. Arcus Business Overview
 Table 63. Arcus Anti-TIGIT Antibody Product
 Table 64. Arcus Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 65. Arcus Recent Development
 Table 66. Astellas Company Details
 Table 67. Astellas Business Overview
 Table 68. Astellas Anti-TIGIT Antibody Product
 Table 69. Astellas Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 70. Astellas Recent Development
 Table 71. BeiGene Company Details
 Table 72. BeiGene Business Overview
 Table 73. BeiGene Anti-TIGIT Antibody Product
 Table 74. BeiGene Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 75. BeiGene Recent Development
 Table 76. BMS Company Details
 Table 77. BMS Business Overview
 Table 78. BMS Anti-TIGIT Antibody Product
 Table 79. BMS Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 80. BMS Recent Development
 Table 81. Junshi Biosciences Company Details
 Table 82. Junshi Biosciences Business Overview
 Table 83. Junshi Biosciences Anti-TIGIT Antibody Product
 Table 84. Junshi Biosciences Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 85. Junshi Biosciences Recent Development
 Table 86. Innovent Biologics Company Details
 Table 87. Innovent Biologics Business Overview
 Table 88. Innovent Biologics Anti-TIGIT Antibody Product
 Table 89. Innovent Biologics Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 90. Innovent Biologics Recent Development
 Table 91. Mereo BioPharma Company Details
 Table 92. Mereo BioPharma Business Overview
 Table 93. Mereo BioPharma Anti-TIGIT Antibody Product
 Table 94. Mereo BioPharma Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 95. Mereo BioPharma Recent Development
 Table 96. Seattle Genetics Company Details
 Table 97. Seattle Genetics Business Overview
 Table 98. Seattle Genetics Anti-TIGIT Antibody Product
 Table 99. Seattle Genetics Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 100. Seattle Genetics Recent Development
 Table 101. Hengrui Medicine Company Details
 Table 102. Hengrui Medicine Business Overview
 Table 103. Hengrui Medicine Anti-TIGIT Antibody Product
 Table 104. Hengrui Medicine Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 105. Hengrui Medicine Recent Development
 Table 106. Compugen Company Details
 Table 107. Compugen Business Overview
 Table 108. Compugen Anti-TIGIT Antibody Product
 Table 109. Compugen Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 110. Compugen Recent Development
 Table 111. Gilead Sciences Company Details
 Table 112. Gilead Sciences Business Overview
 Table 113. Gilead Sciences Anti-TIGIT Antibody Product
 Table 114. Gilead Sciences Revenue in Anti-TIGIT Antibody Business (2020-2025) & (US$ Million)
 Table 115. Gilead Sciences Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Anti-TIGIT Antibody Picture
 Figure 2. Global Anti-TIGIT Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-TIGIT Antibody Market Share by Type: 2024 VS 2031
 Figure 4. Monotherapy Features
 Figure 5. Combination Therapy Features
 Figure 6. Global Anti-TIGIT Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Anti-TIGIT Antibody Market Share by Application: 2024 VS 2031
 Figure 8. Cell Carcinoma Case Studies
 Figure 9. Solid Tumor Case Studies
 Figure 10. Anti-TIGIT Antibody Report Years Considered
 Figure 11. Global Anti-TIGIT Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Anti-TIGIT Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Anti-TIGIT Antibody Market Share by Region: 2024 VS 2031
 Figure 14. Global Anti-TIGIT Antibody Market Share by Players in 2024
 Figure 15. Global Top Anti-TIGIT Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Anti-TIGIT Antibody Revenue in 2024
 Figure 17. North America Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Anti-TIGIT Antibody Market Share by Country (2020-2031)
 Figure 19. United States Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Anti-TIGIT Antibody Market Share by Country (2020-2031)
 Figure 23. Germany Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Anti-TIGIT Antibody Market Share by Region (2020-2031)
 Figure 31. China Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Anti-TIGIT Antibody Market Share by Country (2020-2031)
 Figure 39. Mexico Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Anti-TIGIT Antibody Market Share by Country (2020-2031)
 Figure 43. Turkey Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Anti-TIGIT Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Roche Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 47. Merck Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 48. AstraZeneca Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 49. Arcus Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 50. Astellas Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 51. BeiGene Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 52. BMS Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 53. Junshi Biosciences Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 54. Innovent Biologics Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 55. Mereo BioPharma Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 56. Seattle Genetics Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 57. Hengrui Medicine Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 58. Compugen Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 59. Gilead Sciences Revenue Growth Rate in Anti-TIGIT Antibody Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Anti PD 1 Antibody Market Insights Forecast to 2030
Global Anti PD 1 MAb Market Insights Forecast to 2030
Adalimumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Herceptin Trastuzumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Trastuzumab Monoclonal Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PD 1 and PD L1 Antibody Market Insights Forecast to 2030
Global Anti METTL3 Antibody Market Research Report 2024
B3GALT2 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ipilimumab Market Research Report 2024
Global Anti TNF α Monoclonal Antibody Market Insights Forecast to 2030
Global HER2 Antibody Market Research Report 2025
MZT2B Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global TIGIT Antibody Market Research Report 2024
MT ND3 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tetanus Human Monoclonal Antibody Market Research Report 2024
Global Ustekinumab Market Research Report 2024
EAAT2 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AAT Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions